[Necessity of the development of a melanoma prevention program in Hungary - in the light of epidemiological data] [0.03%]
[匈牙利需要开展防治黑色素瘤的项目-基于流行病学数据]
Veronika Tóth
Veronika Tóth
The prevention and the early diagnosis of melanoma malignum are essential because of the aggressive spreading and poor therapeutic response of the tumor. Since survival mainly depends on the tumor stage, in the first part of the Ph.D. thesi...
Review
Magyar onkologia. 2016 Mar 2;60(1):78-83. DOI: 2016
Miklós Tarján
Miklós Tarján
We aimed to refine the methodology for discriminating ductal (DAP) and acinar adenocarcinomas (AAP) of the prostate preoperatively with a high degree of accuracy, and confirm that prostate carcinoma of ductal origin is a more aggressive sub...
Review
Magyar onkologia. 2016 Mar 2;60(1):72-7. DOI: 2016
[Genetic information from tumor-infiltrating B lymphocytes as a driver tool ("GPS") for anti-tumor T cell CARs] [0.03%]
肿瘤浸润B淋巴细胞的遗传信息作为抗肿瘤T细胞CARs驱动工具（“GPS”）的研究
Beatrix Kotlan,Orsolya Csuka,László Tóth et al.
Beatrix Kotlan et al.
The rapidly growing field of gene therapy techniques to modify T cells with chimeric antigen receptors (CARs) for cancer care solutions, reached considerable achievements. However, there is an urgent need of reliable, well tolerable tumor-a...
Review
Magyar onkologia. 2016 Mar 2;60(1):64-71. DOI: 2016
[Tumorigenesis: interplay of pattern recognition receptors and autophagy] [0.03%]
[肿瘤生成：模式识别受体与自噬的相互作用]
Györgyi Mûzes,Ferenc Sipos
Györgyi Mûzes
According to recent data, the involvement of autophagy in tumor development is unquestionable. Nevertheless, cell-derived pathogen/danger-associated molecular pattern (PAMP/DAMP)-sensing Toll-like receptors (TLRs) are also able to contribut...
Review
Magyar onkologia. 2016 Mar 2;60(1):55-63. DOI: 2016
[The effect of radiotherapy on the antitumor immune response. Possibilities to combine radiotherapy with immunotherapy] [0.03%]
放射治疗对抗肿瘤免疫反应的影响及其与免疫疗法结合的可能方式
Katalin Lumniczky,Géza Sáfrány
Katalin Lumniczky
The past three decades of immunology research led to a drastic increase in the knowledge of antitumor immune response mechanisms and in parallel to a rapid development in various antitumor immune therapy strategies. This will most probably ...
Review
Magyar onkologia. 2016 Mar 2;60(1):46-54. DOI: 2016
Lajos Géczi,Andrea Ladányi,Tímea Vajdics et al.
Lajos Géczi et al.
In this clinical review we provide information regarding advance and main achievements in the immunotherapy of genitourinary, particularly renal cell and prostate cancer. Nivolumab treatment became the new standard of care in locally advanc...
Review
Magyar onkologia. 2016 Mar 2;60(1):41-5. DOI: 2016
Lajos Pusztai,Andrea Ladányi,Borbála Székely et al.
Lajos Pusztai et al.
The prognostic value of tumor infiltrating lymphocytes in breast cancer has long been recognized by histopathologists. These observations were reaffirmed by recent immunohistochemistry and gene expression profiling studies that also reveale...
Review
Magyar onkologia. 2016 Mar 2;60(1):34-40. DOI: 2016
Judit Moldvay,Gyula Ostoros
Judit Moldvay
Lung cancer is the leading cause of cancer death worldwide and also in Hungary, therefore new therapeutic strategies are of great importance. Among immunotherapeutic approaches immune checkpoint inhibition appears to be the most promising. ...
Review
Magyar onkologia. 2016 Mar 2;60(1):28-33. DOI: 2016
[Psychological aspects of immunotherapies in the treatment of malignant melanoma] [0.03%]
免疫治疗恶性黑色素瘤的心理学问题
Péter Kovács,Gitta Pánczél,Krisztina Melegh et al.
Péter Kovács et al.
Psychological problems may arise in connection with oncomedical treatments in three ways: 1. acute and/or 2. chronic ways, as well as 3. co-morbid psychiatric diseases that already exist must also be taken into account. Immunotherapies have...
Review
Magyar onkologia. 2016 Mar 2;60(1):22-7. DOI: 2016
[How to choose the optimal therapy? New issues in the treatment of metastatic melanoma] [0.03%]
如何选择最佳疗法？晚期黑色素瘤治疗的新问题
Judit Oláh,Rolland Gyulai
Judit Oláh
The last few years brought about a complete paradigm-shift in the field of melanoma therapy: eight new drugs, including three immunooncologic, four targeted and one oncolytic virus, became available in the daily practice. These new treatmen...
Review
Magyar onkologia. 2016 Mar 2;60(1):17-21. DOI: 2016